[Reaserch Advance on Langerhans Cell Histiocytosis Review].
摘要
,therefore, according to risk stratification, the regiment and intensity of combination chemotherapy and targeted therapy are drawn up. Prognosis is associates with risk organ infiltration, initial treatment response, and BRAF mutations. Due to the low incidence and lack of systematic knowledge, the clinical understanding of this disease is insufficient, thus the rates of misdiagnosis and therapeutic error are high. In this review, the pathogenesis, clinical manifestations, diagnostic and treatment are summarized. So on to provide a theroretical basis for clinical diagnosis and treatment of the diseases.
引用本文（GB/T 7714）
Zhi-Qiao Fan, Yaozhu Pan, Ping Liu, 等. [Reaserch Advance on Langerhans Cell Histiocytosis Review].[J]. PubMed, 2020.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。